Harvard Bioscience, Inc. announced the appointment of John Duke to its board of directors, effective June 2, 2025. Mr. Duke will also serve on the audit and nominating and governance committees, bringing deep experience in life science tools and business execution to the board.
Mr. Duke currently serves as Chief Executive Officer of Plastic Molding Technology and previously held roles as Executive Vice President and Chief Business Officer of Lyten, Inc. He also spent over twenty years at Corning Incorporated, including eight years as a leader in Corning’s Life Sciences division, demonstrating a track record of driving growth and operational excellence.
In addition to Mr. Duke's appointment, Katherine Eade has been named Lead Independent Director of the company’s board of directors. Thomas Loewald, a director since October 2017, has retired from the board.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.